ADICON Holdings Limited One of the Top Three ICL Service Providers in China is Successfully Listed on Main Board of SEHK Clinical Trials June 30, 2023 Serving Patients and the General Public with High-quality Testing Services and Being a Trusted and Reliable Partner ADICON Holdings Limited…
ADICON Announces Proposed Listing on the Main Board of The Stock Exchange of Hong Kong at an Offer Price of HK$12.32 Per Share Clinical Trials June 19, 2023 ADICON Holdings Limited (ADICON or Company, HKG: 9860), the pioneer of independent clinical laboratory (ICL) and one of the top…
